Catalyst Wire Dossier Catalyst Wire Dossier

EXTOR

amlodipine/valsartan · The Searle Company Limited Pakistan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EXTOR, covering 2025-05-15 to 2025-05-15. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.

See pricing